PURPOSE: To analyse the experience treating soft tissue sarcomas of the head and neck at the Massachusetts General Hospital, Boston. Detailed results have been published previously [17]. PATIENTS AND METHOD: Between 1972 and 1993, 57 patients were treated curatively with radiation alone (n = 13) or combined surgery and pre- and/or postoperative irradiation (n = 44). Gross complete resection was achieved in 82% of patients and margins were negative in 5 patients. Doses ranged from 36.0 to 79.2 Gy (median 64.8 Gy), usually conventionally fractionated. In 16 patients protons were used. Median follow-up time was 4.3 years (range 1.1 to 16.8 years). RESULTS: After 5 years, patients with angiosarcomas (n = 11) and patients with other tumor types (n = 46) had locoregional control rates of 24% and 69%, distant failure rates of 58% and 17%, and overall survival rates of (for overall survival) and T stage (for locoregional control) (p < 0.05). Particularly, gross completely resected T1 tumors had a locoregional control rate of 91%. Patients with locoregional recurrence were at an increased risk to die (p = 0.004 in multivariate analysis). Patients with and without direct tumor extension to neurovascular structures, bones, organs, or skin had distant failure rates of 27% and 0%, respectively (p = 0.031). In multivariate analysis, direct extension was additionally a negative prognosticator of overall survival (p = 0.034). CONCLUSION: 1. Angiosarcomas of the head and neck have a considerably poorer prognosis than other soft tissue sarcomas of this region. 2. Head and neck sarcomas have a higher local recurrence rate than for example soft tissue sarcomas of the extremities. Optimisation of local treatment through combination of surgery and high-dose irradiation, however, can achieve improved results, especially for prognostically favourable subgroups. 3. In addition to tumor grade and size, direct tumor extension may be a useful additional staging parameter.
PURPOSE: To analyse the experience treating soft tissue sarcomas of the head and neck at the Massachusetts General Hospital, Boston. Detailed results have been published previously [17]. PATIENTS AND METHOD: Between 1972 and 1993, 57 patients were treated curatively with radiation alone (n = 13) or combined surgery and pre- and/or postoperative irradiation (n = 44). Gross complete resection was achieved in 82% of patients and margins were negative in 5 patients. Doses ranged from 36.0 to 79.2 Gy (median 64.8 Gy), usually conventionally fractionated. In 16 patients protons were used. Median follow-up time was 4.3 years (range 1.1 to 16.8 years). RESULTS: After 5 years, patients with angiosarcomas (n = 11) and patients with other tumor types (n = 46) had locoregional control rates of 24% and 69%, distant failure rates of 58% and 17%, and overall survival rates of (for overall survival) and T stage (for locoregional control) (p < 0.05). Particularly, gross completely resected T1 tumors had a locoregional control rate of 91%. Patients with locoregional recurrence were at an increased risk to die (p = 0.004 in multivariate analysis). Patients with and without direct tumor extension to neurovascular structures, bones, organs, or skin had distant failure rates of 27% and 0%, respectively (p = 0.031). In multivariate analysis, direct extension was additionally a negative prognosticator of overall survival (p = 0.034). CONCLUSION: 1. Angiosarcomas of the head and neck have a considerably poorer prognosis than other soft tissue sarcomas of this region. 2. Head and neck sarcomas have a higher local recurrence rate than for example soft tissue sarcomas of the extremities. Optimisation of local treatment through combination of surgery and high-dose irradiation, however, can achieve improved results, especially for prognostically favourable subgroups. 3. In addition to tumor grade and size, direct tumor extension may be a useful additional staging parameter.
Authors: H D Suit; H J Mankin; W C Wood; M C Gebhardt; D C Harmon; A Rosenberg; J E Tepper; D Rosenthal Journal: J Clin Oncol Date: 1988-05 Impact factor: 44.544
Authors: W G McKenna; M M Barnes; T J Kinsella; S A Rosenberg; E E Lack; E Glatstein Journal: Int J Radiat Oncol Biol Phys Date: 1987-08 Impact factor: 7.038
Authors: J LeVay; B O'Sullivan; C Catton; R Bell; V Fornasier; B Cummings; Y Hao; D Warr; I Quirt Journal: Int J Radiat Oncol Biol Phys Date: 1993-12-01 Impact factor: 7.038
Authors: R A Eeles; C Fisher; R P A'Hern; M Robinson; P Rhys-Evans; J M Henk; D Archer; C L Harmer Journal: Br J Cancer Date: 1993-07 Impact factor: 7.640
Authors: Brian O'Sullivan; Patrick Gullane; Jonathan Irish; Peter Neligan; Fred Gentili; James Mahoney; Susanna Sellmann; Charles Catton; John Waldron; Dale Brown; Ian Witterick; Jeremy Freeman; Robert Bell Journal: World J Surg Date: 2003-07 Impact factor: 3.352
Authors: Zoltán Takácsi-Nagy; Györgyi Muraközy; Péter Pogány; János Fodor; Zsolt Orosz Journal: Strahlenther Onkol Date: 2009-03-28 Impact factor: 3.621